Admin

``` As performance pressures gradually increase, every move made by Bloomage Biotech (688363.SH) has attracted considerable market attention. Recently, market sources reported that Bloomage Biotech intends to relocate its headquarters from Beijing to Hangzhou. In response, Bloomage Biotech told Xinfeng that the related rumors are not true, but it is

``` Compared to before it was privatized, the business scale of Elon Musk's social platform X has shrunk significantly. According to a Bloomberg report on Saturday, the latest data disclosed to private equity investors shows that for the second quarter of 2025 (ending June 30), X's revenue

``` In global capital markets, a precise and subtle strategy seems to be going mainstream—“hedging the United States.” On one hand, international funds continue to flow into the U.S., pushing U.S. debt holdings to historic highs while actively chasing the rebound in U.S. stocks; on the other

Wall Street is betting that the Federal Reserve will cut interest rates faster and by a larger margin, and this optimistic expectation has driven both the economy and financial markets stronger. However, Wall Street is clearly more optimistic than the Fed itself, and the market may face adjustment risks in

``` Against the backdrop of continued activity in the crypto asset market, custody giant BitGo Holdings Inc. has officially knocked on the door of a US stock market IPO. According to documents filed with the US Securities and Exchange Commission (SEC), the company’s revenue soared to nearly $4.2 billion

``` Elon Musk's brain-computer interface company Neuralink plans to launch a clinical trial in the United States in October, aiming to use its device to translate thoughts into text, bringing new communication possibilities to people with speech impairments. On September 19, according to media reports, the U.S. Food